InvestorsHub Logo

RMacchio

12/30/22 10:40 AM

#912 RE: govprs #911

VV116 is similar to the antiviral remdesivir


That's all you need to know... this drug is a cousin of COVID's hospital mass murderer. Even though remdesivir was only marginally effective in tests and had a 53% fatality rate in it's initial Phase II test it was still approved by the FDA because big pharma was behind it. Since VV116 is not being sponsored by big pharma it will never get approved in the US.